GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Avitar AVTI · USD

Health Care · US listing · 🇺🇸 United States

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Avitar — daily AVTI Delayed

About Avitar

Its shares trade under the ticker AVTI. It has been listed since 11 August 1992. In the fiscal year to 30 September 2007, it reported revenue of $3.1m and a net loss of $2.3m. At that date it held total assets of $1.7m and shareholders' equity of −$6.6m.

Avitar, Inc. develops, manufactures, markets and sells diagnostic test products. The company is headquartered in Canton, Massachusetts. During the fiscal year ended September 30, 2007 (fiscal 2007), the Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company’s foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. Through its wholly owned subsidiary, BJR Security, Inc. (BJR), the Company provided, until April 30, 2007, specialized contraband detection and education services.

Figures and description from our data supplier, not checked against the company's own report.

More about Avitar →

Latest on Avitar

Our reporting

We have not reported on Avitar yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Avitar's ticker?

Avitar trades as AVTI on its US listing, under ISIN US0538013048.

What was Avitar's last closing price?

We have not recorded a close for this listing yet. The chart above carries pricing from TradingView.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.